Sixteenth Century Europe: Expansion and Conflict.
- 期刊名称Renaissance Quarterly
- 作者Rowan, Steven; Mackenney, Richard
- 卷第48卷
- 期第2期
- 印刷ISSN0034-4338
- 文件大小90.76KB
- 发表时间1995-22
- DOI10.2307/2863092
Emerging tyrosine kinase inhibitors for esophageal cancerKu, Geoffrey Y; Ilson, David H · Expert Opinion on Emerging Drugs · 2013
Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junctionKu, Geoffrey Y; Ilson, David H · Expert Review of Anticancer Therapy · 2008
Microsatellite Instability as a Predictive Biomarker for Adjuvant Chemotherapy in Gastric CancerMondaca, Sebastian; Yoon, Sam S.; Strong, Vivian E.; Ku, Geoffrey Y.; Ilson, David H.; Greally, Megan; Janjigian, Yelena Y. · Annals of Surgery · 2018
Regorafenib in Combination with FirstâLine Chemotherapy for Metastatic Esophagogastric CancerMoy, Ryan H.; Dos Santos Fernandes, Gustavo; Jonsson, Philip; Chou, Joanne F.; Basunia, Azfar; Ku, Geoffrey Y.; Chalasani, Sree B.; Boyar, Michelle S.; Goldberg, Zoe; Desai, Avni M.; Gabler, Amelia; Berger, Michael F.; Tang, Laura H.; Hechtman, Jaclyn F.; Kelsen, David P.; Schattner, Mark; Ilson, David H.; Solit, David B.; Taylor, Barry S.; Schultz, Nikolaus; Capanu, Marinela; Janjigian, Yelena Y. · The Oncologist · 2020
Prognostic Significance of Targetable Angiogenic and Growth Factors in Patients Undergoing Resection for Gastric and Gastroesophageal Junction CancersPark, Do Joong; Yoon, Changhwan; Thomas, Nicholas; Ku, Geoffrey Y.; Janjigian, Yelena Y.; Kelsen, David P.; Ilson, David H.; Goodman, Karyn A.; Tang, Laura H.; Strong, Vivian E.; Coit, Daniel G.; Yoon, Sam S. · Annals of Surgical Oncology · 2014
Clinical and molecular predictors of response to immune checkpoint inhibitors in patients with advanced esophagogastric cancerGreally, Megan; Chou, Joanne F; Chatila, Walid K.; Margolis, Matthew; Capanu, Marinela; Hechtman, Jaclyn F; Tuvy, Yaelle; Kundra, Ritika; Daian, Foysal; Ladanyi, Marc; Kelsen, David P.; Ilson, David H.; Berger, Michael F.; Tang, Laura H.; Solit, David B.; Diaz, Luis A.; Schultz, Nikolaus; Janjigian, Yelena Y.; Ku, Geoffrey Y. · Clinical Cancer Research · 2019
Genetic predictors of response to systemic therapy in esophagogastric cancerJanjigian, Yelena Y.; Sanchez-Vega, Francisco; Jonsson, Philip; Chatila, Walid K.; Hechtman, Jaclyn F.; Ku, Geoffrey Y.; Riches, Jamie C.; Tuvy, Yaelle; Kundra, Ritika; Bouvier, Nancy; Vakiani, Efsevia; Gao, Jianjiong; Heins, Zachary J.; Gross, Benjamin E.; Kelsen, David P.; Zhang, Liying; Strong, Vivian E.; Schattner, Mark; Gerdes, Hans; Coit, Daniel G.; Bains, Manjit; Stadler, Zsofia K.; Rusch, Valerie W.; Jones, David R.; Molena, Daniela; Shia, Jinru; Robson, Mark E.; Capanu, Marinela; Middha, Sumit; Zehir, Ahmet; Hyman, David M.; Scaltriti, Maurizio; Ladanyi, Marc; Rosen, Neal; Ilson, David H.; Berger, Michael F.; Tang, Laura; Taylor, Barry S.; Solit, David B.; Schultz, Nikolaus · Cancer Discovery · 2017
Drugs for insomniaZisapel, Nava · Expert Opinion on Emerging Drugs · 2012
Emerging drugs for asthmaQuirce, Santiago; Bobolea, Irina; Barranco, Pilar · Expert Opinion on Emerging Drugs · 2012
Emerging antiviral drugsClercq, Erik De · Expert Opinion on Emerging Drugs · 2008
Emerging therapies for goutSingh, Jasvinder A · Expert Opinion on Emerging Drugs · 2012
Emerging cognitive enhancing drugsBuccafusco, Jerry J · Expert Opinion on Emerging Drugs · 2009
Emerging drugs for hypogonadismEdelstein, Daniel; Dobs, Adrian; Basaria, Shehzad · Expert Opinion on Emerging Drugs · 2006
Emerging drugs for actinic keratosisUlrich, Martina; Drecoll, Ulrike; Stockfleth, Eggert · Expert Opinion on Emerging Drugs · 2010
Emerging drugs for ovarian cancerKelland, Lloyd R · Expert Opinion on Emerging Drugs · 2005